Sinopharm Group Co. Ltd.
SHTDF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $35,238,139 | $54,313,359 | $43,331,766 | $63,808,538 |
| Short-Term Investments | $127 | $158 | $553 | $547 |
| Receivables | $261,218,745 | $206,721,120 | $242,410,688 | $185,790,359 |
| Inventory | $66,814,415 | $62,352,812 | $68,837,707 | $60,027,648 |
| Other Curr. Assets | $11,922,088 | $14,046,293 | $27,782,110 | $16,177,455 |
| Total Curr. Assets | $375,193,514 | $347,447,571 | $382,362,824 | $336,835,100 |
| Property Plant & Equip (Net) | $18,845,579 | $19,632,440 | $20,098,513 | $19,897,657 |
| Goodwill | $6,202,911 | $6,251,565 | $0 | $7,185,729 |
| Intangibles | $3,997,877 | $4,717,685 | $10,124,033 | $2,830,402 |
| Long-Term Investments | $10,549,621 | $10,894,141 | $10,599,887 | $10,550,686 |
| Tax Assets | $2,883,373 | $2,408,387 | $0 | $0 |
| Other NC Assets | $2,655,541 | $1,479,455 | $6,397,860 | $6,095,270 |
| Total NC Assets | $45,134,903 | $45,383,673 | $47,220,293 | $46,559,744 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $420,328,417 | $392,831,244 | $429,583,117 | $383,394,844 |
| Liabilities | – | – | – | – |
| Payables | $152,672,957 | $156,869,715 | $155,834,845 | $154,747,431 |
| Short-Term Debt | $85,913,900 | $62,729,048 | $79,688,778 | $54,730,449 |
| Tax Payable | $1,355,976 | $0 | $0 | $2,988,672 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $35,958,384 | $16,569,839 | $11,150,032 | $17,518,256 |
| Total Curr. Liab. | $279,850,316 | $250,375,588 | $283,237,884 | $241,490,637 |
| LT Debt | $4,435,575 | $8,637,231 | $15,925,362 | $13,834,037 |
| Deferred Rev, NC | $408,301 | $0 | $0 | $448,241 |
| Deferred Tax Liab, NC | $660,375 | $0 | $0 | $788,379 |
| Other NC Liab. | $2,767,320 | $3,871,843 | $4,306,634 | $3,093,964 |
| Total NC Liab. | $11,216,625 | $15,768,354 | $23,912,297 | $21,585,462 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4,552,254 | $5,019,855 | $5,441,084 | $5,217,366 |
| Total Liabilities | $291,066,941 | $266,143,942 | $307,150,181 | $263,076,099 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3,120,656 | $3,120,656 | $3,120,656 | $3,120,656 |
| Retained Earnings | $55,088,521 | $53,744,881 | $50,398,964 | $49,410,060 |
| AOCI | $0 | $22,022,096 | $22,026,173 | $0 |
| Other Equity | $22,027,487 | $0 | $0 | $22,055,339 |
| Total Equity | $80,232,826 | $78,883,795 | $75,541,955 | $74,582,217 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $49,028,650 | $47,803,507 | $46,890,981 | $45,736,528 |
| Total Liab. & Tot. Equity | $420,328,417 | $392,831,244 | $429,583,117 | $383,394,844 |
| Net Debt | $55,111,336 | $17,052,920 | $52,282,374 | $4,755,948 |